Rvnc shareholders with large losses are encouraged to seek counsel to lead the revance therapeutics, inc. class action - contact robbins llp today

San diego, ca / accesswire / january 15, 2025 / robbins llp reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired revance therapeutics, inc. (nasdaq:rvnc) securities between february 29, 2024 and december 6, 2024. revance is a biotechnology company that develops, manufactures, and commercializes neuromodulators for various aesthetic and therapeutic indications in the u.s. and internationally.
RVNC Ratings Summary
RVNC Quant Ranking